We are live on ! Find out more
JDR

Jay D. Rosenbaum Portfolio holdings

AUM $6.69M Turnover 80%
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+2.47%
1 Year Est. Return
+4.68%
3 Year Est. Return
+12.92%
5 Year Est. Return
+74.65%
10 Year Est. Return
+173.05%
AUM
$52.7M
AUM Growth
-$116K
Cap. Flow
-$1.06M
Cap. Flow %
-2.02%
Top 10 Hldgs %
39.06%
Holding
52
New
1
Increased
13
Reduced
31
Closed
2
Avg Time Held
3.3 years
Top 10 Avg Time Held
3.1 years
Top 20 Avg Time Held
3.2 years

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$419K
2
LLY icon
Eli Lilly
LLY
+$208K
3
EW icon
Edwards Lifesciences
EW
+$114K
4
INTC icon
Intel
INTC
+$112K
5
SYK icon
Stryker
SYK
+$102K

Sector Composition

Rank Sector Weight
1 Healthcare 23.39%
2 Technology 23.22%
3 Financials 11.83%
4 Industrials 9.46%
5 Consumer Staples 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$3.76T
$3.49M 6.62%
26,064
-490
-2% -$62.2K
2014 Q4
18 quarters
INTC icon
2
Intel
INTC
$293B
$2.78M 5.27%
57,982
-2,265
-4% -$112K
2014 Q4
18 quarters
PG icon
3
Procter & Gamble
PG
$398B
$2.22M 4.22%
20,256
-30
-0.1% -$3.2K
2014 Q4
18 quarters
SYK icon
4
Stryker
SYK
$121B
$2.18M 4.13%
10,589
-535
-5% -$102K
2014 Q4
18 quarters
AAPL icon
5
Apple
AAPL
$5.11T
$1.84M 3.5%
37,232
-980
-3% -$47.8K
2014 Q4
18 quarters
AMGN icon
6
Amgen
AMGN
$248B
$1.74M 3.29%
9,416
-210
-2% -$37.6K
2014 Q4
18 quarters
EW icon
7
Edwards Lifesciences
EW
$60.6B
$1.69M 3.21%
27,480
-1,881
-6% -$114K
2014 Q4
18 quarters
TJX icon
8
TJX Companies
TJX
$143B
$1.58M 3%
29,865
-1,750
-6% -$93K
2014 Q4
18 quarters
MDT icon
9
Medtronic
MDT
$131B
$1.56M 2.96%
16,040
-120
-0.7% -$11K
2014 Q4
18 quarters
JPM icon
10
JPMorgan Chase
JPM
$876B
$1.52M 2.87%
13,545
+65
+0.5% +$7.17K
2014 Q4
18 quarters
PEP icon
11
PepsiCo
PEP
$194B
$1.42M 2.69%
10,825
-430
-4% -$55.1K
2014 Q4
18 quarters
TMO icon
12
Thermo Fisher Scientific
TMO
$254B
$1.34M 2.53%
4,552
-22
-0.5% -$6.06K
2015 Q4
14 quarters
JNJ icon
13
Johnson & Johnson
JNJ
$671B
$1.3M 2.46%
9,309
-60
-0.6% -$8.3K
2014 Q4
18 quarters
CMCSA icon
14
Comcast
CMCSA
$89.9B
$1.26M 2.39%
29,845
-50
-0.2% -$2.11K
2016 Q2
12 quarters
XOM icon
15
ExxonMobil
XOM
$682B
$1.25M 2.37%
16,299
-102
-0.6% -$7.9K
2014 Q4
18 quarters
ROK icon
16
Rockwell Automation
ROK
$42.9B
$1.19M 2.25%
7,249
-5
-0.1% -$845
2016 Q1
13 quarters
RTX icon
17
RTX
RTX
$267B
$1.19M 2.25%
14,504
-24
-0.2% -$2.01K
2016 Q2
12 quarters
VZ icon
18
Verizon
VZ
$190B
$1.17M 2.23%
20,550
+75
+0.4% +$4.32K
2016 Q1
13 quarters
CTSH icon
19
Cognizant
CTSH
$26.8B
$1.13M 2.15%
17,850
-315
-2% -$20.7K
2014 Q4
18 quarters
USB icon
20
US Bancorp
USB
$92.2B
$1.12M 2.13%
21,435
-455
-2% -$23.4K
2014 Q4
18 quarters
RDS.B
21
DELISTED
Royal Dutch Shell Class B
RDS.B
$1.09M 2.06%
16,535
-1,062
-6% -$69.1K
2014 Q4
18 quarters
BKNG icon
22
Booking.com
BKNG
$115B
$1.08M 2.05%
14,375
-675
-4% -$48.5K
2016 Q1
13 quarters
XLNX
23
DELISTED
Xilinx
XLNX
$917K 1.74%
7,780
– –
2014 Q4
18 quarters
CRM icon
24
Salesforce
CRM
$160B
$908K 1.72%
5,987
+90
+2% +$14.1K
2017 Q1
9 quarters
TRV icon
25
Travelers Companies
TRV
$81.5B
$891K 1.69%
5,960
-40
-0.7% -$5.77K
2016 Q2
12 quarters

Similar funds

Jay D. Rosenbaum's Q2 2019 Portfolio in Review

As of Q2 2019, Jay D. Rosenbaum held 52 positions worth $52.7M, down 0.22% from $52.8M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Jay D. Rosenbaum's Q2 2019 filing shows 1 new, 13 increased, 31 reduced and 2 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 770 shares worth $227K. The largest sale was Biogen, an estimated $419K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Financials.

  • Jay D. Rosenbaum's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 770 shares worth $227K.
  • Jay D. Rosenbaum added most to Amazon in Q2 2019, an estimated $85.7K increase.
  • Jay D. Rosenbaum's biggest Q2 2019 reduction was Edwards Lifesciences, cutting an estimated $114K.
  • Jay D. Rosenbaum fully exited Biogen in Q2 2019, selling an estimated $419K.
  • Jay D. Rosenbaum's ten largest holdings make up 39% of its $52.7M portfolio in Q2 2019.
  • Jay D. Rosenbaum opened 1 new position and closed 2 in Q2 2019.
  • Jay D. Rosenbaum's portfolio value fell 0.22% quarter-over-quarter to $52.7M.

Based on Jay D. Rosenbaum's 13F filing for Q2 2019, filed 1 Aug 2019.